The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.
The global Ketorolac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ketorolac in Postoperative Pain is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ketorolac include Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical and Shandong New Era Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ketorolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac.
Report Scope
The Ketorolac market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ketorolac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Femina Pharma
Fuisz Pharma
Allergan
Technical Chemicals & Products
Apotex Corporation
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Better Pharmaceutical
Yongxin Pharmaceutical Industry
Segment by Type
Tablets
Injection
Eye Drops
Capsule
Segment by Application
Postoperative Pain
Acute Renal Colic
Biliary Colic
Toothache
And The Pain
Trigeminal Neuralgia
Cancer Visceral Pain
Seasonal Allergic Conjunctivitis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ketorolac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.
The global Ketorolac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ketorolac is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ketorolac in Postoperative Pain is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ketorolac include Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, Apotex Corporation, Sichuan Meida Kangjiale Pharmaceutical, Tianjin Hongri Pharmaceutical and Shandong New Era Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ketorolac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac.
Report Scope
The Ketorolac market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ketorolac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Femina Pharma
Fuisz Pharma
Allergan
Technical Chemicals & Products
Apotex Corporation
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Shandong New Era Pharmaceutical
Chengdu Better Pharmaceutical
Yongxin Pharmaceutical Industry
Segment by Type
Tablets
Injection
Eye Drops
Capsule
Segment by Application
Postoperative Pain
Acute Renal Colic
Biliary Colic
Toothache
And The Pain
Trigeminal Neuralgia
Cancer Visceral Pain
Seasonal Allergic Conjunctivitis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ketorolac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ketorolac Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Injection
1.2.4 Eye Drops
1.2.5 Capsule
1.3 Market by Application
1.3.1 Global Ketorolac Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Postoperative Pain
1.3.3 Acute Renal Colic
1.3.4 Biliary Colic
1.3.5 Toothache
1.3.6 And The Pain
1.3.7 Trigeminal Neuralgia
1.3.8 Cancer Visceral Pain
1.3.9 Seasonal Allergic Conjunctivitis
1.3.10 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ketorolac Market Perspective (2019-2030)
2.2 Ketorolac Growth Trends by Region
2.2.1 Global Ketorolac Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ketorolac Historic Market Size by Region (2019-2024)
2.2.3 Ketorolac Forecasted Market Size by Region (2025-2030)
2.3 Ketorolac Market Dynamics
2.3.1 Ketorolac Industry Trends
2.3.2 Ketorolac Market Drivers
2.3.3 Ketorolac Market Challenges
2.3.4 Ketorolac Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ketorolac Players by Revenue
3.1.1 Global Top Ketorolac Players by Revenue (2019-2024)
3.1.2 Global Ketorolac Revenue Market Share by Players (2019-2024)
3.2 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ketorolac Revenue
3.4 Global Ketorolac Market Concentration Ratio
3.4.1 Global Ketorolac Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2023
3.5 Ketorolac Key Players Head office and Area Served
3.6 Key Players Ketorolac Product Solution and Service
3.7 Date of Enter into Ketorolac Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ketorolac Breakdown Data by Type
4.1 Global Ketorolac Historic Market Size by Type (2019-2024)
4.2 Global Ketorolac Forecasted Market Size by Type (2025-2030)
5 Ketorolac Breakdown Data by Application
5.1 Global Ketorolac Historic Market Size by Application (2019-2024)
5.2 Global Ketorolac Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ketorolac Market Size (2019-2030)
6.2 North America Ketorolac Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ketorolac Market Size by Country (2019-2024)
6.4 North America Ketorolac Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ketorolac Market Size (2019-2030)
7.2 Europe Ketorolac Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ketorolac Market Size by Country (2019-2024)
7.4 Europe Ketorolac Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ketorolac Market Size (2019-2030)
8.2 Asia-Pacific Ketorolac Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ketorolac Market Size by Region (2019-2024)
8.4 Asia-Pacific Ketorolac Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ketorolac Market Size (2019-2030)
9.2 Latin America Ketorolac Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ketorolac Market Size by Country (2019-2024)
9.4 Latin America Ketorolac Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ketorolac Market Size (2019-2030)
10.2 Middle East & Africa Ketorolac Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ketorolac Market Size by Country (2019-2024)
10.4 Middle East & Africa Ketorolac Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ketorolac Introduction
11.1.4 Pfizer Revenue in Ketorolac Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Femina Pharma
11.2.1 Femina Pharma Company Detail
11.2.2 Femina Pharma Business Overview
11.2.3 Femina Pharma Ketorolac Introduction
11.2.4 Femina Pharma Revenue in Ketorolac Business (2019-2024)
11.2.5 Femina Pharma Recent Development
11.3 Fuisz Pharma
11.3.1 Fuisz Pharma Company Detail
11.3.2 Fuisz Pharma Business Overview
11.3.3 Fuisz Pharma Ketorolac Introduction
11.3.4 Fuisz Pharma Revenue in Ketorolac Business (2019-2024)
11.3.5 Fuisz Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Ketorolac Introduction
11.4.4 Allergan Revenue in Ketorolac Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 Technical Chemicals & Products
11.5.1 Technical Chemicals & Products Company Detail
11.5.2 Technical Chemicals & Products Business Overview
11.5.3 Technical Chemicals & Products Ketorolac Introduction
11.5.4 Technical Chemicals & Products Revenue in Ketorolac Business (2019-2024)
11.5.5 Technical Chemicals & Products Recent Development
11.6 Apotex Corporation
11.6.1 Apotex Corporation Company Detail
11.6.2 Apotex Corporation Business Overview
11.6.3 Apotex Corporation Ketorolac Introduction
11.6.4 Apotex Corporation Revenue in Ketorolac Business (2019-2024)
11.6.5 Apotex Corporation Recent Development
11.7 Sichuan Meida Kangjiale Pharmaceutical
11.7.1 Sichuan Meida Kangjiale Pharmaceutical Company Detail
11.7.2 Sichuan Meida Kangjiale Pharmaceutical Business Overview
11.7.3 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Introduction
11.7.4 Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2019-2024)
11.7.5 Sichuan Meida Kangjiale Pharmaceutical Recent Development
11.8 Tianjin Hongri Pharmaceutical
11.8.1 Tianjin Hongri Pharmaceutical Company Detail
11.8.2 Tianjin Hongri Pharmaceutical Business Overview
11.8.3 Tianjin Hongri Pharmaceutical Ketorolac Introduction
11.8.4 Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2019-2024)
11.8.5 Tianjin Hongri Pharmaceutical Recent Development
11.9 Shandong New Era Pharmaceutical
11.9.1 Shandong New Era Pharmaceutical Company Detail
11.9.2 Shandong New Era Pharmaceutical Business Overview
11.9.3 Shandong New Era Pharmaceutical Ketorolac Introduction
11.9.4 Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2019-2024)
11.9.5 Shandong New Era Pharmaceutical Recent Development
11.10 Chengdu Better Pharmaceutical
11.10.1 Chengdu Better Pharmaceutical Company Detail
11.10.2 Chengdu Better Pharmaceutical Business Overview
11.10.3 Chengdu Better Pharmaceutical Ketorolac Introduction
11.10.4 Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2019-2024)
11.10.5 Chengdu Better Pharmaceutical Recent Development
11.11 Yongxin Pharmaceutical Industry
11.11.1 Yongxin Pharmaceutical Industry Company Detail
11.11.2 Yongxin Pharmaceutical Industry Business Overview
11.11.3 Yongxin Pharmaceutical Industry Ketorolac Introduction
11.11.4 Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2019-2024)
11.11.5 Yongxin Pharmaceutical Industry Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ketorolac Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Injection
Table 4. Key Players of Eye Drops
Table 5. Key Players of Capsule
Table 6. Global Ketorolac Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Ketorolac Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Ketorolac Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Ketorolac Market Share by Region (2019-2024)
Table 10. Global Ketorolac Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Ketorolac Market Share by Region (2025-2030)
Table 12. Ketorolac Market Trends
Table 13. Ketorolac Market Drivers
Table 14. Ketorolac Market Challenges
Table 15. Ketorolac Market Restraints
Table 16. Global Ketorolac Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Ketorolac Market Share by Players (2019-2024)
Table 18. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2023)
Table 19. Ranking of Global Top Ketorolac Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Ketorolac Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ketorolac Product Solution and Service
Table 23. Date of Enter into Ketorolac Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ketorolac Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Ketorolac Revenue Market Share by Type (2019-2024)
Table 27. Global Ketorolac Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Ketorolac Revenue Market Share by Type (2025-2030)
Table 29. Global Ketorolac Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Ketorolac Revenue Market Share by Application (2019-2024)
Table 31. Global Ketorolac Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Ketorolac Revenue Market Share by Application (2025-2030)
Table 33. North America Ketorolac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Ketorolac Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Ketorolac Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Ketorolac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Ketorolac Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Ketorolac Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Ketorolac Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Ketorolac Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Ketorolac Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Ketorolac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Ketorolac Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ketorolac Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ketorolac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Ketorolac Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Ketorolac Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Ketorolac Product
Table 51. Pfizer Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Femina Pharma Company Detail
Table 54. Femina Pharma Business Overview
Table 55. Femina Pharma Ketorolac Product
Table 56. Femina Pharma Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 57. Femina Pharma Recent Development
Table 58. Fuisz Pharma Company Detail
Table 59. Fuisz Pharma Business Overview
Table 60. Fuisz Pharma Ketorolac Product
Table 61. Fuisz Pharma Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 62. Fuisz Pharma Recent Development
Table 63. Allergan Company Detail
Table 64. Allergan Business Overview
Table 65. Allergan Ketorolac Product
Table 66. Allergan Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. Technical Chemicals & Products Company Detail
Table 69. Technical Chemicals & Products Business Overview
Table 70. Technical Chemicals & Products Ketorolac Product
Table 71. Technical Chemicals & Products Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 72. Technical Chemicals & Products Recent Development
Table 73. Apotex Corporation Company Detail
Table 74. Apotex Corporation Business Overview
Table 75. Apotex Corporation Ketorolac Product
Table 76. Apotex Corporation Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 77. Apotex Corporation Recent Development
Table 78. Sichuan Meida Kangjiale Pharmaceutical Company Detail
Table 79. Sichuan Meida Kangjiale Pharmaceutical Business Overview
Table 80. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product
Table 81. Sichuan Meida Kangjiale Pharmaceutical Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 82. Sichuan Meida Kangjiale Pharmaceutical Recent Development
Table 83. Tianjin Hongri Pharmaceutical Company Detail
Table 84. Tianjin Hongri Pharmaceutical Business Overview
Table 85. Tianjin Hongri Pharmaceutical Ketorolac Product
Table 86. Tianjin Hongri Pharmaceutical Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 87. Tianjin Hongri Pharmaceutical Recent Development
Table 88. Shandong New Era Pharmaceutical Company Detail
Table 89. Shandong New Era Pharmaceutical Business Overview
Table 90. Shandong New Era Pharmaceutical Ketorolac Product
Table 91. Shandong New Era Pharmaceutical Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 92. Shandong New Era Pharmaceutical Recent Development
Table 93. Chengdu Better Pharmaceutical Company Detail
Table 94. Chengdu Better Pharmaceutical Business Overview
Table 95. Chengdu Better Pharmaceutical Ketorolac Product
Table 96. Chengdu Better Pharmaceutical Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 97. Chengdu Better Pharmaceutical Recent Development
Table 98. Yongxin Pharmaceutical Industry Company Detail
Table 99. Yongxin Pharmaceutical Industry Business Overview
Table 100. Yongxin Pharmaceutical Industry Ketorolac Product
Table 101. Yongxin Pharmaceutical Industry Revenue in Ketorolac Business (2019-2024) & (US$ Million)
Table 102. Yongxin Pharmaceutical Industry Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ketorolac Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ketorolac Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Injection Features
Figure 5. Eye Drops Features
Figure 6. Capsule Features
Figure 7. Global Ketorolac Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Ketorolac Market Share by Application: 2023 VS 2030
Figure 9. Postoperative Pain Case Studies
Figure 10. Acute Renal Colic Case Studies
Figure 11. Biliary Colic Case Studies
Figure 12. Toothache Case Studies
Figure 13. And The Pain Case Studies
Figure 14. Trigeminal Neuralgia Case Studies
Figure 15. Cancer Visceral Pain Case Studies
Figure 16. Seasonal Allergic Conjunctivitis Case Studies
Figure 17. Other Case Studies
Figure 18. Ketorolac Report Years Considered
Figure 19. Global Ketorolac Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Ketorolac Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Ketorolac Market Share by Region: 2023 VS 2030
Figure 22. Global Ketorolac Market Share by Players in 2023
Figure 23. Global Top Ketorolac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Ketorolac Revenue in 2023
Figure 25. North America Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Ketorolac Market Share by Country (2019-2030)
Figure 27. United States Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Ketorolac Market Share by Country (2019-2030)
Figure 31. Germany Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Ketorolac Market Share by Region (2019-2030)
Figure 39. China Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Ketorolac Market Share by Country (2019-2030)
Figure 47. Mexico Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Ketorolac Market Share by Country (2019-2030)
Figure 51. Turkey Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Ketorolac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Pfizer Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 54. Femina Pharma Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 55. Fuisz Pharma Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 56. Allergan Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 57. Technical Chemicals & Products Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 58. Apotex Corporation Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 59. Sichuan Meida Kangjiale Pharmaceutical Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 60. Tianjin Hongri Pharmaceutical Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 61. Shandong New Era Pharmaceutical Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 62. Chengdu Better Pharmaceutical Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 63. Yongxin Pharmaceutical Industry Revenue Growth Rate in Ketorolac Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
